Counterfeit phosphodiesterase type 5 inhibitors pose significant safety risks
Open Access
- 18 January 2010
- journal article
- review article
- Published by Hindawi Limited in International Journal of Clinical Practice
- Vol. 64 (4), 497-504
- https://doi.org/10.1111/j.1742-1241.2009.02328.x
Abstract
Counterfeit drugs are inherently dangerous and a growing problem; counterfeiters are becoming increasingly sophisticated. Growth of the counterfeit medication market is attributable in part to phosphodiesterase type 5 inhibitor (PDE5i) medications for erectile dysfunction (ED). Millions of counterfeit PDE5is are seized yearly and account for the bulk of all counterfeit pharmaceutical product seizures. It has been estimated that up to 2.5 million men in Europe are exposed to illicit sildenafil, suggesting that there may be as many illegal as legal users of sildenafil. Analysis of the contents of counterfeit PDE5is shows inconsistent doses of active pharmaceutical ingredients (from 0% to > 200% of labelled dose), contaminants (including talcum powder, commercial paint and printer ink) and alternative ingredients that are potentially hazardous. In one analysis, only 10.1% of samples were within 10% of the labelled tablet strength. Estimates place the proportion of counterfeit medications sold over the Internet from 44% to 90%. Of men who purchase prescription-only medication for ED without a prescription, 67% do so using the Internet. Counterfeit PDE5is pose direct and indirect risks to health, including circumvention of the healthcare system. More than 30% of men reported no healthcare interaction when purchasing ED medications. Because > 65% actually had ED, these men missed an opportunity for evaluation of comorbidities (e.g. diabetes and hypertension). Globally, increased obstacles for counterfeiters are necessary to combat pharmaceutical counterfeiting, including fines and penalties. The worldwide nature of the counterfeit problem requires proper coordination between countries to ensure adequate enforcement. Locally, physicians who treat ED need to inform patients of the dangers of ordering PDE5is via the Internet.Keywords
This publication has 26 references indexed in Scilit:
- 2D and 3D DOSY 1H NMR, a useful tool for analysis of complex mixtures: Application to herbal drugs or dietary supplements for erectile dysfunctionJournal of Pharmaceutical and Biomedical Analysis, 2009
- The MHRA's three‐pronged strategy to tackle counterfeitsPrescriber, 2008
- Bitter pillsBMJ, 2007
- Bad medicineNature Biotechnology, 2007
- Prescription Drug Wholesalers: Drug Distribution and the Inspection Process (A Florida Perspective)Journal of Pharmacy Practice, 2006
- Counterfeit Drugs and States’ Efforts to Combat the ProblemJournal of Pharmacy Practice, 2006
- Buying prescription drugs on the internet: promises and pitfalls.Cleveland Clinic Journal of Medicine, 2006
- Sex, Lies, and NiagraJAMA, 2004
- Online Prescribing of Sildanefil (Viagra) on the World Wide WebJournal of Medical Internet Research, 1999
- Direct Sale of Sildenafil (Viagra) to Consumers over the InternetThe New England Journal of Medicine, 1999